The Trump administration is preparing to issue an executive order to temporarily suspend federal funding for “gain-of-function” virus research. This type of research involves altering pathogens to make them more transmissible or dangerous, often for the purpose of studying potential pandemic threats. The move is in response to ongoing Republican concerns, with some blaming such research for the origins of COVID-19, particularly pointing to the Wuhan Institute of Virology in China.
While the connection between gain-of-function research and the COVID-19 pandemic remains unproven—many scientists assert there is no evidence to support the lab-leak theory—critics argue that the risks of such research far outweigh the potential benefits. Proponents, however, emphasize its importance for understanding and mitigating emerging viral threats.
The executive order comes amid a broader push for oversight in virology research, with the Biden administration having already introduced measures to regulate these studies. The moratorium could exempt certain viruses, such as the H5N1 bird flu, which some researchers argue are critical to study due to their pandemic potential.
Dr. Jay Bhattacharya, a vocal critic of pandemic policies and President Trump’s nominee for the National Institutes of Health, supports the funding freeze. As the debate over gain-of-function research continues, this decision underscores the growing divide between public health priorities and concerns over biosecurity.
